Drug intelligence / Profile preview

homobarringtonie

Development stage
Preclinical
Modality
Small Molecules
Administration
Subcutaneous
01

Overview

Homobarringtonie is a natural alkaloid that belongs to the cephalotaxine class, structurally related to homoharringtonine and omacetaxine mepesuccinate. It acts primarily as a protein synthesis inhibitor, binding to ribosomes and interfering with elongation of nascent peptide chains, which leads to inhibition of protein synthesis, induction of apoptosis, and cell cycle arrest in tumor cells. Homobarringtonie has been studied for efficacy in the treatment of hematological malignancies, particularly acute myeloid leukemia (AML) and other myeloid cancers, often in combination regimens. It is noted for cytotoxic and antitumor activities and appears to share mechanisms with homoharringtonine, but is referenced as a distinct entity in therapeutic combinations in recent clinical research[7].

Other names
homobarringtonie
02

Targets

HSF1 (Heat shock factor protein 1)80S A-site (Eukaryotic ribosomal aminoacyl-tRNA site (A-site))

Beyond the preview

Go deeper on homobarringtonie.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on homobarringtonie.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call